The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X. C.
Right arrow Articles by Strom, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X. C.
Right arrow Articles by Strom, T. B.
The Journal of Immunology, 2000, 164: 1193-1199.
Copyright © 2000 by The American Association of Immunologists

Blocking the Common {gamma}-Chain of Cytokine Receptors Induces T Cell Apoptosis and Long-Term Islet Allograft Survival1

Xian Chang Li2,*, Azine Ima*, Yongsheng Li*, Xin Xiao Zheng*, Thomas R. Malek{dagger} and Terry B. Strom*

* Department of Medicine, Division of Immunology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215; and {dagger} Department of Microbiology and Immunology, University of Miami, Miami, FL 33101

The common {gamma}c-chain is an essential signaling component shared by all known T cell growth factor (TCGF) receptors (i.e., IL-2, IL-4, IL-7, IL-9, and IL-15). In the present study, we have studied the effect of {gamma}c-chain blockade on T cell activation and allograft rejection. Treatment of B6AF1 (H-2b/d.k) recipient mice with anti-{gamma}c mAbs induced long-term survival of DBA/2 (H-2d) islet allografts (>150 days, n = 8), whereas control Ab-treated mice rejected the islet allografts within 17 days (n = 6). The state of engraftment induced by the anti-{gamma}c mAbs was remarkably stable, as recipient mice bearing the primary islet allografts accepted a second DBA/2 islet allograft without further immunosuppression and systemic administration of high doses of IL-2Ig fusion protein failed to provoke rejection. Blocking the {gamma}c-chain inhibited T cell proliferation and induced T cell apoptosis by repressing expression of Bcl-2. Our data suggest that one means of inducing T cell apoptosis and stable allograft survival can be achieved via {gamma}c-chain blockade.




This article has been cited by other articles:


Home page
DiabetesHome page
A. Plesner, P. Liston, R. Tan, R. G. Korneluk, and C. B. Verchere
The X-Linked Inhibitor of Apoptosis Protein Enhances Survival of Murine Islet Allografts
Diabetes, September 1, 2005; 54(9): 2533 - 2540.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Vu, F. Amanullah, Y. Li, G. Demirci, M. H. Sayegh, and X. C. Li
Different Costimulatory and Growth Factor Requirements for CD4+ and CD8+ T Cell-Mediated Rejection
J. Immunol., July 1, 2004; 173(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Demirci, T. B. Strom, and X. C. Li
Islet Allograft Rejection in Nonobese Diabetic Mice Involves the Common {gamma}-Chain and CD28/CD154-Dependent and -Independent Mechanisms
J. Immunol., October 1, 2003; 171(7): 3878 - 3885.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. AKDIS, A. TRAUTMANN, S. KLUNKER, I. DAIGLE, U. C. KUCUKSEZER, W. DEGLMANN, R. DISCH, K. BLASER, and C. A. AKDIS
T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells
FASEB J, June 1, 2003; 17(9): 1026 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li
On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response
J. Immunol., May 1, 2002; 168(9): 4382 - 4390.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Rabinovitch, W. L. Suarez-Pinzon, A.M. J. Shapiro, R. V. Rajotte, and R. Power
Combination Therapy With Sirolimus and Interleukin-2 Prevents Spontaneous and Recurrent Autoimmune Diabetes in NOD Mice
Diabetes, March 1, 2002; 51(3): 638 - 645.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. Jones, J. Ha, M. A. Williams, A. B. Adams, M. M. Durham, P. A. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen
The Role of the IL-2 Pathway in Costimulation Blockade-Resistant Rejection of Allografts
J. Immunol., February 1, 2002; 168(3): 1123 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Behbod, R. A. Erwin-Cohen, M.-E. Wang, B. W. Trawick, X. Qu, R. Verani, B. D. Kahan, S. M. Stepkowski, and R. A. Kirken
Concomitant Inhibition of Janus Kinase 3 and Calcineurin-Dependent Signaling Pathways Synergistically Prolongs the Survival of Rat Heart Allografts
J. Immunol., March 15, 2001; 166(6): 3724 - 3732.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. G. Smith, E. M. Bolton, H. Ruchatz, X.-q. Wei, F. Y. Liew, and J. A. Bradley
Selective Blockade of IL-15 by Soluble IL-15 Receptor {alpha}-Chain Enhances Cardiac Allograft Survival
J. Immunol., September 15, 2000; 165(6): 3444 - 3450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.